| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |